VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need. 

Education

Pharmaceutical

VistaGen Therapeutics

Shawn K. Singh

Michelle Peters Wellington

Imogene Dunn

Margie Schneider

Ester Salmán

Cindy Anderson

Mark Flather

Mark A. McPartland

Allen Cato III

Louis Monti

Ross A. Baker

Greg Weilersbacher

Trisha Fitzmaurice

Jessica R. Haskell

Joshua Prince

Reid Adler

Mark J. Ginski

Leadership Team

Clinical and Medical Team

Legal and Compliance

Project Management

Regulatory and Quality Affairs

Teams at VistaGen Therapeutics

Leadership Team

Clinical and Medical Team

Legal and Compliance

Project Management

Regulatory and Quality Affairs